PMID: 42224699

In T2D inadequately controlled with metformin, orforglipron reduced HbA 1c more than oral semaglutide at 52 wk.

Lau Darren, ACP Journal Club Editorial Team at McMaster University

Annals of internal medicine · 2026

Vol. 179, Issue 6, pp. JC62

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansAdministration, OralDiabetes Mellitus, Type 2Glycated HemoglobinHypoglycemic AgentsMetforminPyridonesSemaglutideOxadiazolesFluorine Compounds

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.